ACE and cystic fibrosis: A study involving 180 CF patients examined the effect of biallelic ACE polymorphisms, revealing that patients with biallelic ACE deletions experienced earlier onset of clinical symptoms and were at higher risk of lung deterioration compared to patients with monoallelic or biallelic insertions [11].